Sep 14, 2026
NDPS Act Reform 2026: Proportionality Era Begins for Pharma
India is amending the NDPS Act to introduce "proportionality" in enforcement. Here's what CBN's new self-regulation push and the Vision…
Read MoreRegulatory updates, compliance insights, and industry analysis from the ACPL team.
India is amending the NDPS Act to introduce "proportionality" in enforcement. Here's what CBN's new self-regulation push and the Vision…
Read MoreIndia's June 2026 narcotics enforcement surge and the DCC-approved real-time tracking portal raise the bar for pharmaceutical supply chain compliance.
Read MoreA new controlled substance under NDPS was notified in March 2026 with stock and registration deadlines in July–August 2026. Here's…
Read MoreIndia's NDPS regulatory landscape shifted significantly in late 2025 and early 2026. Here's what pharmaceutical companies must act on now.
Read More